In systemic lupus erythematosus (SLE), a complex multi-organ autoimmune disease characterized by persistent inflammation and autoantibody production, dysregulation of ILC subsets is increasingly recognized as a critical contributor to pathogenesis. This evidence concerns the gene CCL27 and systemic lupus erythematosus.